Akebia Therapeutics Earning Date (AKBA)

USA |NASDAQ |USD

AKBA Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 23, 2022 Dec 2021 $-0.29 $-0.34 $-0.60
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 23, 2022 Dec 2021 $52.58M $48.76M $56.70M

Akebia Therapeutics's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 2021.

AKBA Earnings Date & History Chart

AKBA Earnings & Revenue Forecast

AKBA Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-0.29 $-0.34 $-0.22
Mar 2022 5 $-0.30 $-0.37 $-0.23
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-1.57 $-1.64 $-1.45
Dec 2022 7 $-0.76 $-1.12 $-0.37

AKBA Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-0.29 $-0.29 $-0.28
Mar 2022 0 / 0 $-0.31 $-0.31 $-0.31
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 3 $-1.59 $-1.59 $-1.40
Dec 2022 3 / 0 $-0.78 $-0.78 $-0.79

AKBA Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $52.58M $46.50M $60.29M
Mar 2022 4 $50.06M $34.00M $84.40M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $208.06M $200.47M $229.21M
Dec 2022 7 $26.49M $215.14M $37.71M

AKBA Earnings Date & Revenue History

AKBA Earnings History

|
Show More
Show More

AKBA Revenue History

|
Show More
Show More

Akebia Therapeutics Next Earnings Date & Report

AKBA Next Earnings Date & Report Preview: Dec 2021 (FQ)

AKBA's next earnings date is Wednesday, Feb 23, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 6 analysts, the average EPS estimation for Akebia Therapeutics's next quarterly earnings is $-0.29, with a low EPS estimation of $-0.34, and a high estimation of $-0.22.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 1 downward. The EPS 1 month trend is $-0.29, the last 2 month trend is $-0.29, and the 3 month trend is $-0.28.

Based on 5 analysts, the average revenue estimation is $52.58M, with a low revenue estimation of $46.50M, and a high estimation of $60.29M.

Akebia Therapeutics Previous Earnings Dates & Reports

AKBA Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Akebia Therapeutics's previous earnings date was Nov 4, 2021 for its fiscal quarter ended Sep 30, 2021.

AKBA's earnings per share (EPS) was $-0.34, missing the consensus analysts forecast of $-0.29 by -16.24%.

The EPS was higher than the previous fiscal quarter (Jun 2021) by -33.33%, and higher than the same period a year before (Sep 2020) by -19.05%.

Revenues were $48.76M, worse than the forecast of $49.67M by -1.84%, down by -7.86% from the previous quarter , and down by -18.72% from the same period last year.

The company reported a net income of $-59.54M.

Free cash flow for the quarter was $-56.27M , compared to $-63.14M last quarter and $-27.19M a year before.

AKBA ended the quarter with $123.21M in total debt, a decrease of -0.82% compared to the previous quarter, and an increase of 50.39% compared to the same quarter a year before.

AKBA Previous Earnings Date & Report Recap: Dec 2020 (FY)

Akebia Therapeutics's previous annual earnings date was Feb 25, 2021 for its fiscal year ended Dec 31, 2020.

AKBA's earnings per share (EPS) was $-1.93, beating the consensus analysts forecast of $-2.58 by -25.19% , and higher than the previous year's EPS (Dec 2019) by -18.22%.

Revenues were $295.31M, better than the forecast of $288.47M by 2.37%, and down by -11.85% from previous year's revenue.

The company reported a net income of $-383.46M.

Akebia Therapeutics reported a free cash flow of $-110.70M for its fiscal year, compared to $-264.10M a year ago.

The company ended the fiscal year with $101.66M in total debt, an increase of 25.83% compared to the previous year.